In-Silico testing and validation of Cardiovascular IMplantable devices Read more

SIMCor is a three-and-a-half-year (January 2021 - June 2024) Horizon 2020 research and innovation action developing a computational platform for in-silico development, validation and regulatory approval of cardiovascular implantable devices

Objective 1

Provide proof-of-validation for virtual cohorts and computer-based simulation of cardiovascular device implantation and performance

Objective 2

Develop standards and protocols for in-silico testing and validation of cardiovascular devices

Objective 3

Quantify the benefits of in-silico testing for healthcare, industry and society as a whole

Objective 4

Accelerate the integration of in-silico testing into the medical device regulatory approval process, the market and the clinics

Objective 5

Contribute to the European Open Science Cloud with data, virtual cohorts, simulation models, methodologies, standards and guidelines

Saint Peter’s Church. Credits: Moahim, CC0, via Wikimedia Commons.

Device effect simulation domain of the SIMCor VRE.

Strong international visitor attendance at MEDICA + COMPAMED in Düsseldorf © Constanze Tillmann/ Messe Düsseldorf via

Vienna State Opera at night. Credits: Pierre Blaché, CC0, via Wikimedia Commons

San Francisco city skyline. Credits: Lisafern, CC0, via Wikimedia Commons.